Cardioplegia and cardiac surgery: Pharmacological arrest and cardioprotection during global ischemia and reperfusion

Pharmacology and Therapeutics

Volumn 127, Issue 1, 2010, Pages 41-52

  Chambers, David J ^a   Fallouh, Hazem B ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Cardioplegia; Depolarization; Ischemia; Polarization; Reperfusion

Indexed keywords

ADENOSINE; CALCIUM CHANNEL BLOCKING AGENT; ESMOLOL; LIDOCAINE; POTASSIUM CHANNEL; POTASSIUM CHANNEL STIMULATING AGENT; PROCAINE; SODIUM CHANNEL; SODIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL; CARDIOPLEGIC AGENT; CARDIOTONIC AGENT;

CARDIOPLEGIA; DEMOGRAPHY; DESENSITIZATION; DRUG MECHANISM; EXCITATION CONTRACTION COUPLING; HEART ARREST; HEART DEPOLARIZATION; HEART MUSCLE FIBER MEMBRANE POTENTIAL; HEART MUSCLE FIBER MEMBRANE STEADY POTENTIAL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; HEART SURGERY; HUMAN; HYPERKALEMIA; HYPERTENSION; HYPOCALCEMIA; ISCHEMIC PRECONDITIONING; MYOFILAMENT; NONHUMAN; PATIENT SAFETY; PRIORITY JOURNAL; REVIEW; TACHYCARDIA; ANIMAL; CARDIOPULMONARY BYPASS; CHEMICALLY INDUCED; DRUG EFFECTS; PROCEDURES;

ANIMALS; CALCIUM CHANNELS; CARDIOPLEGIC SOLUTIONS; CARDIOPULMONARY BYPASS; CARDIOTONIC AGENTS; HEART ARREST, INDUCED; HUMANS; MYOCARDIAL ISCHEMIA; MYOCARDIAL REPERFUSION; SODIUM CHANNELS;

EID: 77953537394     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2010.04.001     Document Type: Review

References (154)

1. Alekseev A.E., Jovanovic A., Lopez J.R., Terzic A. Adenosine slows the rate of K(+)-induced membrane depolarization in ventricular cardiomyocytes: Possible implication in hyperkalemic cardioplegia. J Mol Cell Cardiol 1996, 28(6):1193-1202.
2. Amrani M., Ledingham S., Jayakumar J., Allen N.J., Rothery S., Severs N., et al. Detrimental effects of temperature on the efficacy of the University of Wisconsin solution when used for cardioplegia at moderate hypothermia. Comparison with the St. Thomas Hospital solution at 4 degrees C and 20 degrees C. Circulation 1992, 86(5 Suppl):II280-II288.
3. Arlock P., Wohlfart B., Sjoberg T., Steen S. The negative inotropic effect of esmolol on isolated cardiac muscle. Scand Cardiovasc J 2005, 39(4):250-254.
4. Ascione R., Caputo M., Gomes W.J., Lotto A.A., Bryan A.J., Angelini G.D., et al. Myocardial injury in hypertrophic hearts of patients undergoing aortic valve surgery using cold or warm blood cardioplegia. Eur J Cardiothorac Surg 2002, 21(3):440-446.
5. Attwell D., Cohen I., Eisner D., Ohba M., Ojeda C. The steady state TTX-sensitive ("window") sodium current in cardiac Purkinje fibres. Pflugers Arch 1979, 379(2):137-142.
6. Balderman S.C., Schwartz K., Aldrich J., Chan A.K. Cardioplegic arrest of the myocardium with calcium blocking agents. J Cardiovasc Pharmacol 1992, 19(1):1-9.
7. Belardinelli L., Giles W.R., West A. Ionic mechanisms of adenosine actions in pacemaker cells from rabbit heart. J Physiol 1988, 405:615-633.
8. Bers D.M. Cardiac excitation-contraction coupling. Nature 2002, 415(6868):198-205.
9. Bessho R., Chambers D.J. Myocardial protection: The efficacy of an ultra-short-acting beta-blocker, esmolol, as a cardioplegic agent. J Thorac Cardiovasc Surg 2001, 122(5):993-1003.
10. Bessho R., Chambers D.J. Myocardial protection with oxygenated esmolol cardioplegia during prolonged normothermic ischemia in the rat. J Thorac Cardiovasc Surg 2002, 124(2):340-351.
11. Boehm D.H., Human P.A., von Oppell U., Owen P., Reichenspurner H., Opie L.H., et al. Adenosine cardioplegia: Reducing reperfusion injury of the ischaemic myocardium?. Eur J Cardiothorac Surg 1991, 5(10):542-545.
12. Boengler K., Schulz R., Heusch G. Loss of cardioprotection with ageing. Cardiovasc Res 2009, 83(2):247-261.
13. Boldt J., Brosch C., Lehmann A., Suttner S., Isgro F. The prophylactic use of the beta-blocker esmolol in combination with phosphodiesterase III inhibitor enoximone in elderly cardiac surgery patients. Anesth Analg 2004, 99(4):1009-1017.
14. Booth J.V., Spahn D.R., McRae R.L., Chesnut L.C., El-Moalem H., Atwell D.M., et al. Esmolol improves left ventricular function via enhanced beta-adrenergic receptor signaling in a canine model of coronary revascularization. Anesthesiology 2002, 97(1):162-169.
15. Braimbridge M.V., Chayen J., Bitensky L., Hearse D.J., Jynge P., Cankovic-Darracott S. Cold cardioplegia or continuous coronary perfusion? Report on preliminary clinical experience as assessed cytochemically. J Thorac Cardiovasc Surg 1977, 74(6):900-906.
16. Breisblatt W.M., Stein K.L., Wolfe C.J., Follansbee W.P., Capozzi J., Armitage J.M., et al. Acute myocardial dysfunction and recovery: A common occurrence after coronary bypass surgery. J Am Coll Cardiol 1990, 15(6):1261-1269.
17. Bretschneider H.J. Survival time and recuperative time of the heart in normothermia and hypothermia. Verh Dtsch Ges Kreislaufforsch 1964, 30:11-34.
18. Bretschneider H.J., Hubner G., Knoll D., Lohr B., Nordbeck H., Spieckermann P.G. Myocardial resistance and tolerance to ischemia: Physiological and biochemical basis. J Cardiovasc Surg (Torino) 1975, 16(3):241-260.
19. Brown P.S., Holland F.W., Parenteau G.L., Clark R.E. Magnesium ion is beneficial in hypothermic crystalloid cardioplegia. Ann Thorac Surg 1991, 51(3):359-366. discussion 367.
20. Brown D.L., Ransom D.M., Hall J.A., Leicht C.H., Schroeder D.R., Offord K.P. Regional anesthesia and local anesthetic-induced systemic toxicity: Seizure frequency and accompanying cardiovascular changes. Anesth Analg 1995, 81(2):321-328.
21. Buckberg G.D., Allen B.S., Beyersdorf F. Blood cardioplegic strategies during adult cardiac operations. Ischemia-reperfusion in cardiac surgery 1993, 181-227. Kluwer Academic Publishers, AA Dordrecht. H.M. Piper, C.J. Preusse (Eds.).
22. Buckberg G.D., Brazier J.R., Nelson R.L., Goldstein S.M., McConnell D.H., Cooper N. Studies of the effects of hypothermia on regional myocardial blood flow and metabolism during cardiopulmonary bypass. I. The adequately perfused beating, fibrillating, and arrested heart. J Thorac Cardiovasc Surg 1977, 73(1):87-94.
23. Burns P.G., Krukenkamp I.B., Caldarone C.A., Gaudette G.R., Bukhari E.A., Levitsky S. Does cardiopulmonary bypass alone elicit myoprotective preconditioning?. Circulation 1995, 92(9 Suppl):II447-II451.
24. Chakraborti S., Chakraborti T., Mandal M., Mandal A., Das S., Ghosh S. Protective role of magnesium in cardiovascular diseases: A review. Mol Cell Biochem 2002, 238(1-2):163-179.
25. Chambers J. Aortic stenosis. Bmj 2005, 330(7495):801-802.
26. Chambers D.J., Braimbridge M.V. Cardioplegia with an extracellular formulation. Ischemia-reperfusion in cardiac surgery 1993, 135-179. Kluwer Academic Publishers, AA Dordrecht. H.M. Piper, C.J. Preusse (Eds.).
27. Chambers D.J., Hearse D.J. Cardioplegia and surgical ischemia. Heart physiology and pathophysiology 2001, 887-925. Academic Press, San Diego. Fourth ed. N. Sperelakis, Y. Kurachi, A. Terzic, M.V. Cohen (Eds.).
28. Chapman R.A., Tunstall J. The calcium paradox of the heart. Prog Biophys Mol Biol 1987, 50(2):67-96.
29. Chambers A.J., Fallouh H., Kentish J.C., Chambers D.J. Cardioplegia by polarised arrest: Experimental studies with potential for clinical application. Eur J Heart Failure Suppl 2009, 8(2):ii149.
30. Christakis G.T., Fremes S.E., Weisel R.D., Tittley J.G., Mickle D.A., Ivanov J., et al. Diltiazem cardioplegia. A balance of risk and benefit. J Thorac Cardiovasc Surg 1986, 91(5):647-661.
31. Cohen G., Feder-Elituv R., Iazetta J., Bunting P., Mallidi H., Bozinovski J., et al. Phase 2 studies of adenosine cardioplegia. Circulation 1998, 98(19 Suppl):II225-II233.
32. Corvera J.S., Kin H., Dobson G.P., Kerendi F., Halkos M.E., Katzmark S., et al. Polarized arrest with warm or cold adenosine/lidocaine blood cardioplegia is equivalent to hypothermic potassium blood cardioplegia. J Thorac Cardiovasc Surg 2005, 129(3):599-606.
33. de Jong J.W. Cardioplegia and calcium antagonists: A review. Ann Thorac Surg 1986, 42(5):593-598.
34. de Jong J.W., van der Meer P., van Loon H., Owen P., Opie L.H. Adenosine as adjunct to potassium cardioplegia: Effect on function, energy metabolism, and electrophysiology. J Thorac Cardiovasc Surg 1990, 100(3):445-454.
35. Deng C.Y., Lin S.G., Zhang W.C., Kuang S.J., Qian W.M., Wu S.L., et al. Esmolol inhibits Na+ current in rat ventricular myocytes. Methods Find Exp Clin Pharmacol 2006, 28(10):697-702.
36. Dillon J.S., Nayler W.G. [3H]-verapamil binding to rat cardiac sarcolemmal membrane fragments; an effect of ischaemia. Br J Pharmacol 1987, 90(1):99-109.
37. Dobson G.P., Jones M.W. Adenosine and lidocaine: A new concept in nondepolarizing surgical myocardial arrest, protection, and preservation. J Thorac Cardiovasc Surg 2004, 127(3):794-805.
38. Dorman B.H., Cavallo M.J., Hinton R.B., Roy R.C., Spinale F.G. Preservation of myocyte contractile function after hypothermic, hyperkalemic cardioplegic arrest with 2, 3-butanedione monoxime. J Thorac Cardiovasc Surg 1996, 111(3):621-629.
39. Dorman B.H., Hebbar L., Clair M.J., Hinton R.B., Roy R.C., Spinale F.G. Potassium channel opener-augmented cardioplegia: Protection of myocyte contractility with chronic left ventricular dysfunction. Circulation 1997, 96(9 Suppl):II-253-II-259.
40. Dorman B.H., Hebbar L., Zellner J.L., New R.B., Houck W.V., Acsell J., et al. ATP-sensitive potassium channel activation before cardioplegia. Effects on ventricular and myocyte function. Circulation 1998, 98(19 Suppl):II176-II183.
41. Downey J.M., Cohen M.V. Why do we still not have cardioprotective drugs?. Circ J 2009, 73(7):1171-1177.
42. Downey J.M., Davis A.M., Cohen M.V. Signaling pathways in ischemic preconditioning. Heart Fail Rev 2007, 12(3-4):181-188.
43. Ducko C.T., Stephenson E.R., Jayawant A.M., Vigilance D.W., Damiano R.J. Potassium channel openers: Are they effective as pretreatment or additives to cardioplegia?. Ann Thorac Surg 2000, 69(5):1363-1368.
44. Ede M., Ye J., Gregorash L., Summers R., Pargaonkar S., LeHouerou D., et al. Beyond hyperkalemia: beta-blocker-induced cardiac arrest for normothermic cardiac operations. Ann Thorac Surg 1997, 63(3):721-727.
45. Fallouh H.B., Chambers D.J. ICVTS on-line discussion A. The safety of using millimolar doses of lidocaine as cardioplegia. Interact Cardiovasc Thorac Surg 2007, 6(2):176.
46. Fallouh H.B., McLatchie L.M., Bardswell S.C., Shattock M.J., Chambers D.J., Kentish J.C. Myocardial arrest by esmolol: Negative inotropy induced by calcium and sodium channel blockade. J Mol Cell Cardiol 2008, 44:S49-S50.
47. Fallouh H.B., McLatchie L.M., Shattock M.J., Chambers D.J., Kentish J.C. Esmolol as a cardioplegic agent: An effect beyond (beta)-blockade. Circulation 2007, 116:II-323-II-324.
48. Ferdinandy P., Schulz R., Baxter G.F. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 2007, 59(4):418-458.
49. Fleckenstein A., Fleckenstein-Grun G. Mechanism of action of calcium antagonists in heart and vascular smooth muscle. Eur Heart J 1988, 9(Suppl H):95-99.
50. Follette D.M., Mulder D.G., Maloney J.V., Buckberg G.D. Advantages of blood cardioplegia over continuous coronary perfusion or intermittent ischemia. Experimental and clinical study. J Thorac Cardiovasc Surg 1978, 76(5):604-619.
51. Fremes S.E., Levy S.L., Christakis G.T., Walker S.E., Iazetta J., Mallidi H.R., et al. Phase 1 human trial of adenosine-potassium cardioplegia. Circulation 1996, 94(9 Suppl):II370-II375.
52. Fremes S.E., Zhang J., Furukawa R.D., Mickle D.A., Weisel R.D. Cardiac storage with University of Wisconsin solution, calcium, and magnesium. J Heart Lung Transplant 1995, 14(5):916-925.
53. Galinanes M., Shattock M.J., Hearse D.J. Effects of potassium channel modulation during global ischaemia in isolated rat heart with and without cardioplegia. Cardiovasc Res 1992, 26(11):1063-1068.
54. Garcia-Dorado D., Theroux P., Duran J.M., Solares J., Alonso J., Sanz E., et al. Selective inhibition of the contractile apparatus. A new approach to modification of infarct size, infarct composition, and infarct geometry during coronary artery occlusion and reperfusion. Circulation 1992, 85(3):1160-1174.
55. Geissler H.J., Davis K.L., Laine G.A., Ostrin E.J., Mehlhorn U., Hekmat K., et al. Myocardial protection with high-dose beta-blockade in acute myocardial ischemia. Eur J Cardiothorac Surg 2000, 17(1):63-70.
56. Gibbon J.H. Application of a mechanical heart and lung apparatus to cardiac surgery. Minn Med 1954, 37(3):171-185. passim.
57. Gorczynski R.J. Basic pharmacology of esmolol. Am J Cardiol 1985, 56(11):3F-13F.
58. Gwathmey J.K., Hajjar R.J., Solaro R.J. Contractile deactivation and uncoupling of crossbridges. Effects of 2, 3-butanedione monoxime on mammalian myocardium. Circ Res 1991, 69(5):1280-1292.
59. Hausenloy D.J., Yellon D.M. Remote ischaemic preconditioning: Underlying mechanisms and clinical application. Cardiovasc Res 2008, 79(3):377-386.
60. He G.W., Yang C.Q. Superiority of hyperpolarizing to depolarizing cardioplegia in protection of coronary endothelial function. J Thorac Cardiovasc Surg 1997, 114(4):643-650.
61. Hearse D.J., Braimbridge M.V., Jynge P. Protection of the ischemic myocardium: cardioplegia 1981, Raven Press, New York.
62. Hearse D.J., O'Brien K., Braimbridge M.V. Protection of the myocardium during ischemic arrest. Dose-response curves for procaine and lignocaine in cardioplegic solutions. J Thorac Cardiovasc Surg 1981, 81(6):873-879.
63. Hearse D.J., Stewart D.A., Braimbridge M.V. Cellular protection during myocardial ischemia: The development and characterization of a procedure for the induction of reversible ischemic arrest. Circulation 1976, 54(2):193-202.
64. Hearse D.J., Stewart D.A., Braimbridge M.V. Myocardial protection during ischemic cardiac arrest. The importance of magnesium in cardioplegic infusates. J Thorac Cardiovasc Surg 1978, 75(6):877-885.
65. Hebbar L., Houck W.V., Zellner J.L., Dorman B.H., Spinale F.G. Temporal relation of ATP-sensitive potassium-channel activation and contractility before cardioplegia. Ann Thorac Surg 1998, 65(4):1077-1082.
66. Hiraoka M. Metabolic pathways for ion homeostasis and persistent Na(+) current. J Cardiovasc Electrophysiol 2006, 17(Suppl 1):S124-S126.
67. Hohnloser S.H., Meinertz T., Klingenheben T., Sydow B., Just H. Usefulness of esmolol in unstable angina pectoris. European Esmolol Study Group. Am J Cardiol 1991, 67(16):1319-1323.
68. Hosoda H., Sunamori M., Suzuki A. Effect of pinacidil on rat hearts undergoing hypothermic cardioplegia. Ann Thorac Surg 1994, 58(6):1631-1636.
69. Ingwall J.S. Energy metabolism in heart failure and remodelling. Cardiovasc Res 2009, 81(3):412-419.
70. Iseri L.T., French J.H. Magnesium: Nature's physiologic calcium blocker. Am Heart J 1984, 108(1):188-193.
71. Jahangir A., Terzic A. K(ATP) channel therapeutics at the bedside. J Mol Cell Cardiol 2005, 39(1):99-112.
72. Jayawant A.M., Lawton J.S., Hsia P.W., Damiano R.J. Hyperpolarized cardioplegic arrest with nicorandil: Advantages over other potassium channel openers 1997, 96(9 Suppl):II-240-II-246.
73. Jayawant A.M., Stephenson E.R., Damiano R.J. 2, 3-Butanedione monoxime cardioplegia: Advantages over hyperkalemia in blood-perfused isolated hearts. Ann Thorac Surg 1999, 67(3):618-623.
74. Jovanovic A., Alekseev A.E., Lopez J.R., Shen W.K., Terzic A. Adenosine prevents hyperkalemia-induced calcium loading in cardiac cells: Relevance for cardioplegia. Ann Thorac Surg 1997, 63(1):153-161.
75. Jynge P. Protection of the ischemic myocardium: Cold chemical cardioplegia, coronary infustates and the importance of cellular calcium control. Thorac Cardiovasc Surg 1980, 28(5):310-321.
76. Jynge P., Hearse D.J., Braimbridge M.V. Myocardial protection during ischemic cardiac arrest. A possible hazard with calcium-free cardioplegic infusates. J Thorac Cardiovasc Surg 1977, 73(6):848-855.
77. Jynge P., Hearse D.J., Braimbridge M.V. Protection of the ischemic myocardium. Volume-duration relationships and the efficacy of myocardial infusates. J Thorac Cardiovasc Surg 1978, 76(5):698-705.
78. Jynge P., Hearse D.J., Feuvray D., Mahalu W., Cankovic-Darracott S., O'Brien K., et al. The St. Thomas' hospital cardioplegic solution: A characterization in two species. Scand J Thorac Cardiovasc Surg Suppl 1981, 30:1-28.
79. Karthik S., Grayson A.D., Oo A.Y., Fabri B.M. A survey of current myocardial protection practices during coronary artery bypass grafting. Ann R Coll Surg Engl 2004, 86(6):413-415.
80. Katayama O., Ledingham S.J., Amrani M., Smolenski R.T., Lachno D.R., Jayakumar J., et al. Functional and metabolic effects of adenosine in cardioplegia: role of temperature and concentration. Ann Thorac Surg 1997, 63(2):449-454. discussion 454-445.
81. Katz A.M., Tada M. The "stone heart": A challenge to the biochemist. Am J Cardiol 1972, 29(4):578-580.
82. Kharbanda R.K., Mortensen U.M., White P.A., Kristiansen S.B., Schmidt M.R., Hoschtitzky J.A., et al. Transient limb ischemia induces remote ischemic preconditioning in vivo. Circulation 2002, 106(23):2881-2883.
83. Kirsch U., Rodewald G., Kalmar P. Induced ischemic arrest. Clinical experience with cardioplegia in open-heart surgery. J Thorac Cardiovasc Surg 1972, 63(1):121-130.
84. Kleber A.G. Resting membrane potential, extracellular potassium activity, and intracellular sodium activity during acute global ischemia in isolated perfused guinea pig hearts. Circ Res 1983, 52(4):442-450.
85. Kronon M.T., Allen B.S., Hernan J., Halldorsson A.O., Rahman S., Buckberg G.D., et al. Superiority of magnesium cardioplegia in neonatal myocardial protection. Ann Thorac Surg 1999, 68(6):2285-2291. discussion 2291-2282.
86. Kuhn-Regnier F., Geissler H.J., Marohl S., Mehlhorn U., De Vivie E.R. Beta-blockade in 200 coronary bypass grafting procedures. Thorac Cardiovasc Surg 2002, 50(3):164-167.
87. Kuhn-Regnier F., Natour E., Dhein S., Dapunt O., Geissler H.J., LaRose K., et al. Beta-blockade versus Buckberg blood-cardioplegia in coronary bypass operation. Eur J Cardiothorac Surg 1999, 15(1):67-74.
88. Lawton J.S., Harrington G.C., Allen C.T., Hsia P.W., Damiano R.J. Myocardial protection with pinacidil cardioplegia in the blood-perfused heart. Ann Thorac Surg 1996, 61(6):1680-1688.
89. Lawton J.S., Sepic J.D., Allen C.T., Hsia P.W., Damiano R.J. Myocardial protection with potassium-channel openers is as effective as St. Thomas' solution in the rabbit heart. Ann Thorac Surg 1996, 62(1):31-38. discussion 38-39.
90. Lewis F.J., Taufic M. Closure of atrial septal defects with the aid of hypothermia; experimental accomplishments and the report of one successful case. Surgery 1953, 33(1):52-59.
91. Lopez J.R., Jahangir R., Jahangir A., Shen W.K., Terzic A. Potassium channel openers prevent potassium-induced calcium loading of cardiac cells: Possible implications in cardioplegia. J Thorac Cardiovasc Surg 1996, 112(3):820-831.
92. Luo W., Li B., Chen R., Huang R., Lin G. Effect of ischemic postconditioning in adult valve replacement. Eur J Cardiothorac Surg 2008, 33(2):203-208.
93. Maruyama Y., Chambers D.J. Does ischemic postconditioning improve myocardial protection after conventional cardioplegia?. J Mol Cell Cardiol 2008, 44:761.
94. Maruyama Y., Chambers D.J. Myocardial protection: efficacy of a novel magnesium-based cardioplegia (RS-C) compared to St Thomas' Hospital cardioplegic solution. Interact Cardiovasc Thorac Surg 2008, 7(5):745-749.
95. Maskal S.L., Cohen N.M., Hsia P.W., Wechsler A.S., Damiano R.J. Hyperpolarized cardiac arrest with a potassium-channel opener, aprikalim. J Thorac Cardiovasc Surg 1995, 110(4 Pt 1):1083-1095.
96. McAllister R.E., Noble D., Tsien R.W. Reconstruction of the electrical activity of cardiac Purkinje fibres. J Physiol 1975, 251(1):1-59.
97. McCully J.D., Levitsky S. Mechanisms of in vitro cardioprotective action of magnesium on the aging myocardium. Magnes Res 1997, 10(2):157-168.
98. McCully J.D., Levitsky S. The mitochondrial K(ATP) channel and cardioprotection. Ann Thorac Surg 2003, 75(2):S667-S673.
99. Mehlhorn U., Allen S.J., Adams D.L., Davis K.L., Gogola G.R., Warters R.D. Cardiac surgical conditions induced by beta-blockade: Effect on myocardial fluid balance. Ann Thorac Surg 1996, 62(1):143-150.
100. Mehlhorn U., Sauer H., Kuhn-Regnier F., Sudkamp M., Dhein S., Eberhardt F., et al. Myocardial beta-blockade as an alternative to cardioplegic arrest during coronary artery surgery. Cardiovasc Surg 1999, 7(5):549-557.
101. Melrose D.G., Dreyer B., Bentall H.H., Baker J.B. Elective cardiac arrest. Lancet 1955, 269(6879):21-22.
102. Menasche P., Mouas C., Grousset C. Is potassium channel opening an effective form of preconditioning before cardioplegia?. Ann Thorac Surg 1996, 61(6):1764-1768.
103. Mentzer R.M., Birjiniuk V., Khuri S., Lowe J.E., Rahko P.S., Weisel R.D., et al. Adenosine myocardial protection: Preliminary results of a phase II clinical trial. Ann Surg 1999, 229(5):643-649. discussion 649-650.
104. Miller R.D. Local anesthetics. Basic and clinical pharmacology 1998, 425-433. Appleton and Lange, Stamford. 7th ed. B.G. Katzung (Ed.).
105. Murry C.E., Jennings R.B., Reimer K.A. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986, 74(5):1124-1136.
106. Narahashi T. Tetrodotoxin: a brief history. Proc Jpn Acad Ser B Phys Biol Sci 2008, 84(5):147-154.
107. Niedergerke R., Orkand R.K. The dependence of the action potential of the frog's heart on the external and intracellular sodium concentration. J Physiol 1966, 184(2):312-334.
108. Onorati F., De Feo M., Mastroroberto P., di Virgilio A., Esposito A., Polistena M., et al. Unstable angina and non-ST segment elevation: Surgical revascularization with different strategies. Eur J Cardiothorac Surg 2005, 27(6):1043-1050.
109. Opie L.H. Channels, pumps, and exchangers. Heart Physiology From Cell to Circulation 2004, 73-118. Lippincott Williams & Wilkins, Philadelphia. Fourth ed.
110. Opie L.H., Bers D.M. Excitation-contraction coupling and calcium. Heart Physiology From Cell to Circulation 2004, 159-185. Lippincott Williams & Wilkins, Philadelphia. Fourth ed.
111. Pirk J., Kolar F., Ost'adal B., Sedivy J., Stambergova A., Kellovsky P. The effect of the ultrashort beta-blocker esmolol on cardiac function recovery: An experimental study. Eur J Cardiothorac Surg 1999, 15(2):199-203.
112. Popovic J., Mitic R., Sabo A., Mikov M., Jakovljevic V., Dakovic-Svajcer K. Spline functions in convolutional modeling of verapamil bioavailability and bioequivalence. II: Study in healthy volunteers. Eur J Drug Metab Pharmacokinet 2006, 31(2):87-96.
113. Preusse C.J. Cardioplegia with an intracellular formulation. Ischemia-reperfusion in cardiac surgery 1993, 107-134. Kluwer Academic Publishers, Dordrecht. H.M. Piper, C.J. Preusse (Eds.).
114. Przyklenk K., Bauer B., Ovize M., Kloner R.A., Whittaker P. Regional ischemic 'preconditioning' protects remote virgin myocardium from subsequent sustained coronary occlusion. Circulation 1993, 87(3):893-899.
115. Qiu Y., Galinanes M., Hearse D.J. Protective effect of nicorandil as an additive to the solution for continuous warm cardioplegia. J Thorac Cardiovasc Surg 1995, 110(4 Pt 1):1063-1072.
116. Quast U., Guillon J.M., Cavero I. Cellular pharmacology of potassium channel openers in vascular smooth muscle. Cardiovasc Res 1994, 28(6):805-810.
117. Rastan A.J., Eckenstein J.I., Hentschel B., Funkat A.K., Gummert J.F., Doll N., et al. Emergency coronary artery bypass graft surgery for acute coronary syndrome: Beating heart versus conventional cardioplegic cardiac arrest strategies. Circulation 2006, 114(1 Suppl):I477-I485.
118. Ricci M., Salerno T.A. Cardiopulmonary bypass without ischemic arrest: A myocardial protection strategy for high-risk patients requiring urgent CABG. J Card Surg 2006, 21(5):498-499.
119. Rich T.L., Langer G.A., Klassen M.G. Two components of coupling calcium in single ventricular cell of rabbits and rats. Am J Physiol 1988, 254(5 Pt 2):H937-H946.
120. Ringer S. A further contribution regarding the influence of the different constituents of the blood on the contraction of the heart. J Physiol 1883, 4(1):29-42.
121. Robinson L.A., Schwarz G.D., Goddard D.B., Fleming W.H., Galbraith T.A. Myocardial protection for acquired heart disease surgery: Results of a national survey. Ann Thorac Surg 1995, 59(2):361-372.
122. Saint D.A. The role of the persistent Na(+) current during cardiac ischemia and hypoxia. J Cardiovasc Electrophysiol 2006, 17(Suppl 1):S96-S103.
123. Schubert T., Vetter H., Owen P., Reichart B., Opie L.H. Adenosine cardioplegia. Adenosine versus potassium cardioplegia: effects on cardiac arrest and postischemic recovery in the isolated rat heart. J Thorac Cardiovasc Surg 1989, 98(6):1057-1065.
124. Sellevold O.F., Berg E.M., Levang O.W. Procaine is effective for minimizing postischemic ventricular fibrillation in cardiac surgery. Anesth Analg 1995, 81(5):932-938.
125. Shattock M.J., Hearse D.J., Fry C.H. The ionic basis of the anti-ischemic and anti-arrhythmic properties of magnesium in the heart. J Am Coll Nutr 1987, 6(1):27-33.
126. Sloots K.L., Vinten-Johansen J., Dobson G.P. Warm nondepolarizing adenosine and lidocaine cardioplegia: continuous versus intermittent delivery. J Thorac Cardiovasc Surg 2007, 133(5):1171-1178.
127. Snabaitis A.K., Chambers D. Long-term myocardial preservation: Beneficial and additive effects of polarized arrest (Na+-channel blockade), Na+/H+-exchange inhibition, and Na+/K+/2Cl-cotransport inhibition combined with calcium desensitization. Transplantation 1999, 68(10):1444-1453.
128. Snabaitis A.K., Shattock M.J., Chambers D.J. Comparison of polarized and depolarized arrest in the isolated rat heart for long-term preservation. Circulation 1997, 96(9):3148-3156.
129. Snabaitis A.K., Shattock M.J., Chambers D.J. Long-term myocardial preservation: Effects of hyperkalemia, sodium channel, and Na/K/2Cl cotransport inhibition on extracellular potassium accumulation during hypothermic storage. J Thorac Cardiovasc Surg 1999, 118(1):123-134.
130. Sperelakis N., Sunagawa M., Nakamura M. Electrogenesis of the resting potential. Heart physiology and pathophysiology 2001, 175-198. Academic Press, San Diego. Fourth ed. N. Sperelakis, Y. Kurachi, A. Terzic, M.V. Cohen (Eds.).
131. Steenbergen C., Murphy E., Watts J.A., London R.E. Correlation between cytosolic free calcium, contracture, ATP, and irreversible ischemic injury in perfused rat heart. Circ Res 1990, 66(1):135-146.
132. Sternbergh W.C., Brunsting L.A., Abd-Elfattah A.S., Wechsler A.S. Basal metabolic energy requirements of polarized and depolarized arrest in rat heart. Am J Physiol 1989, 256(3 Pt 2):H846-H851.
133. Stringham J.C., Paulsen K.L., Southard J.H., Fields B.L., Belzer F.O. Improved myocardial ischemic tolerance by contractile inhibition with 2,3-butanedione monoxime. Ann Thorac Surg 1992, 54(5):852-859. discussion 859-860.
134. Sugimoto S., Puddu P.E., Monti F., Schiariti M., Campa P.P., Marino B. Pretreatment with the adenosine triphosphate-sensitive potassium channel opener nicorandil and improved myocardial protection during high-potassium cardioplegic hypoxia. J Thorac Cardiovasc Surg 1994, 108(3):455-466.
135. Swanson D.K., Pasaoglu I., Berkoff H.A., Southard J.A., Hegge J.O. Improved heart preservation with UW preservation solution. J Heart Transplant 1988, 7(6):456-467.
136. Taggart D.P., Kaul S., Boden W.E., Ferguson T.B., Guyton R.A., Mack M.J., et al. Revascularization for unprotected left main stem coronary artery stenosis stenting or surgery. J Am Coll Cardiol 2008, 51(9):885-892.
137. Thomson P.D., Melmon K.L., Richardson J.A., Cohn K., Steinbrunn W., Cudihee R., et al. Lidocaine pharmacokinetics in advanced heart failure, liver disease, and renal failure in humans. Ann Intern Med 1973, 78(4):499-508.
138. Tsukube T., McCully J.D., Metz K.R., Cook C.U., Levitsky S. Amelioration of ischemic calcium overload correlates with high-energy phosphates in senescent myocardium. Am J Physiol 1997, 273(1 Pt 2):H418-H425.
139. Tyers G.F., Todd G.J., Niebauer I.M., Manley N.J., Waldhausen J.A. Effect of intracoronary tetrodotoxin on recovery of the isolated working rat heart from sixty minutes of ischemia. Circulation 1974, 50(2 Suppl):II175-II180.
140. Tyers G.F., Todd G.J., Niebauer I.M., Manley N.J., Waldhausen J.A. The mechanism of myocardial damage following potassium citrate (Melrose) cardioplegia. Surgery 1975, 78(1):45-53.
141. Vaage J., Valen G. Preconditioning and cardiac surgery. Ann Thorac Surg 2003, 75(2):S709-S714.
142. Vahl C.F., Bonz A., Hagl C., Hagl S. Reversible desensitization of the myocardial contractile apparatus for calcium. A new concept for improving tolerance to cold ischemia in human myocardium?. Eur J Cardiothorac Surg 1994, 8(7):370-378.
143. Vahl C.F., Bonz A., Hagl C., Timek T., Herold U., Fuchs H., et al. "Cardioplegia on the contractile apparatus level": Evaluation of a new concept for myocardial preservation in perfused pig hearts. Thorac Cardiovasc Surg 1995, 43(4):185-193.
144. Venugopal V., Ludman A., Yellon D.M., Hausenloy D.J. 'Conditioning' the heart during surgery. Eur J Cardiothorac Surg 2009, 35(6):977-987.
145. Vinten-Johansen J. Postconditioning: a mechanical maneuver that triggers biological and molecular cardioprotective responses to reperfusion. Heart Fail Rev 2007, 12(3-4):235-244.
146. Vinten-Johansen J., Zhao Z.Q., Jiang R., Zatta A.J., Dobson G.P. Preconditioning and postconditioning: Innate cardioprotection from ischemia-reperfusion injury. J Appl Physiol 2007, 103(4):1441-1448.
147. Vouhe P.R., Helias J., Grondin C.M. Myocardial protection through cold cardioplegia using diltiazem, a calcium channel blocker. Ann Thorac Surg 1980, 30(4):342-348.
148. Walgama O.V., Shattock M.J., Chambers D.J. Efficacy of a K-ATP channel opener to induce myocardial arrest: species differences. J Mol Cell Cardiol 2000, 32:A40.
149. Walgama O.V., Shattock M.J., Chambers D.J. Myocardial arrest and protection: dual effect of a K-channel opener and Na-channel blocker as an alternative to hyperkalemia. J Mol Cell Cardiol 2000, 32:A41.
150. Ward J.W., McBurney A., Farrow P.R., Sharp P. Pharmacokinetics and hypotensive effect in healthy volunteers of pinacidil, a new potent vasodilator. Eur J Clin Pharmacol 1984, 26(5):603-608.
151. Yamaguchi S., Watanabe G., Tomita S., Tabata S. Lidocaine-magnesium blood cardioplegia was equivalent to potassium blood cardioplegia in left ventricular function of canine heart. Interact Cardiovasc Thorac Surg 2007, 6(2):172-176.
152. Yamamoto F., Manning A.S., Braimbridge M.V., Hearse D.J. Calcium antagonists and myocardial protection during cardioplegic arrest. Adv Myocardiol 1985, 6:545-562.
153. Zaroslinski J., Borgman R.J., O'Donnell J.P., Anderson W.G., Erhardt P.W., Kam S.T., et al. Ultra-short acting beta-blockers: A proposal for the treatment of the critically ill patient. Life Sci 1982, 31(9):899-907.
154. Zhang J., Furukawa R.D., Fremes S.E., Mickle D.A., Weisel R.D. Effects of butanedione monoxime and temperature on prolonged cardiac storage. Ann Thorac Surg 1997, 63(2):388-394.